Circulating antibodies and macrophages as modulators of adenovirus pharmacology.

@article{Khare2013CirculatingAA,
  title={Circulating antibodies and macrophages as modulators of adenovirus pharmacology.},
  author={Reeti Khare and Matthew L. Hillestad and Zhili Xu and Andrew P Byrnes and Michael Anthony Barry},
  journal={Journal of virology},
  year={2013},
  volume={87 7},
  pages={3678-86}
}
Adenovirus serotype 5 (Ad5) naturally infects the liver after intravenous injection, making it a candidate for hepatocyte-directed gene transfer. While Ad5 can be efficient, most of the dose is destroyed by liver Kupffer cells before it can reach hepatocytes. In contrast, Ad5 bearing the hexon from Ad6 (Ad5/6) evades Kupffer cells. While Ad5/6 dramatically increases hepatocyte transduction in BALB/c mice, it has surprisingly little effect on C57BL/6 mice. To determine the source of this strain… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 21 references

Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer.

Molecular therapy : the journal of the American Society of Gene Therapy • 2011
View 12 Excerpts

Scavenger 520 receptor A: a new route for adenovirus

H. J. Haisma, M. Boesjes, +5 authors A. R. Bellu
Mol Pharm • 2009
View 1 Excerpt

Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo.

Proceedings of the National Academy of Sciences of the United States of America • 2008
View 1 Excerpt

Analyzing antibody-Fc-receptor interactions.

Methods in molecular biology • 2008
View 2 Excerpts

Similar Papers

Loading similar papers…